<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T15:40:58Z</responseDate><request verb="GetRecord" identifier="oai:digital.lib.washington.edu:1773/55239" metadataPrefix="dim">https://digital.lib.washington.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:digital.lib.washington.edu:1773/55239</identifier><datestamp>2026-02-07T11:10:45Z</datestamp><setSpec>com_1773_4888</setSpec><setSpec>col_1773_4923</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Henikoff, Steve</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Danyko, Cassidy</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-02-05T19:36:18Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2026-02-05</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2025</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">Danyko_washington_0250E_29030.pdf</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1773/55239</dim:field>
   <dim:field mdschema="dc" element="description">Thesis (Ph.D.)--University of Washington, 2025</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Chromatin accessibility, especially the process of nucleosome eviction is critical for geneactivation in eukaryotic cells. The Brahma-associated Factor (BAF) complex plays a key role in
creating accessible chromatin at gene promoters enhancers in an ATP-dependent manner and by
direct binding to DNA and nucleosomes In Chapter 2, I study the importance of BAF in a
developmental context by testing the interdependence of ecdysone-receptor transcription factor
binding with BAF ATPase nucleosome remodeling activity for gene activation during ecdysoneinduced
metamorphosis in Drosophila melanogaster. To measure changes in the chromatin
landscape, I use a chromatin profiling technology developed in our lab, Cleavage Under Targets
&amp; Tagmentation (CUT&amp;Tag), which allows mapping of targets genome-wide. Furthermore I use
a version for targeting Accessible Chromatin (CUTAC), which maps RNA Polymerase IIassociated
DNA accessibility genome-wide In Chapter 3, I test the use of BAF-inhibitors in a
triple-negative breast cancer cell-line in combination with the cyclin dependent kinase 12,
CDK12, transcriptional kinase inhibitor. I measure the chromatin changes underlying observed
synergy in cell cytotoxicity and cell-death in MDA-MB-231 cells treated with both FHT1015
BAF inhibitor and THZ531 CDK12 inhibition. The combined treatment leads to loss of
chromatin and DNA integrity, supporting apoptosis. My work elucidates the importance of ATPdependent
BAF activity with transcription factor binding in normal development and highlights
the utility of BAF loss of function as a cancer-killing strategies</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table1_2_3.xlsx; spreadsheet; Tables 1-3.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table4_Brg1_peaks_annotated.tsv; spreadsheet; Table 4.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table5_CDK12_peaks_annotated.tsv; spreadsheet; Table 5.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table6_Brg1CDK12_promoters.bed; spreadsheet; Table 6.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table7_Brg1CDK12_enhancers.bed; spreadsheet; Table 7.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table8_CUTAC_enhancers_cotreatment.xlsx; spreadsheet; Table 8.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table9_CUTAC_genes_cotreatment.xlsx; spreadsheet; Table 9.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table10_cutac_synergy_deseq2.xlsx; spreadsheet; Table 10.</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart">Table11_synergy_gsea.xlsx; spreadsheet; Table 11.</dim:field>
   <dim:field mdschema="dc" element="rights">none</dim:field>
   <dim:field mdschema="dc" element="subject">cancer</dim:field>
   <dim:field mdschema="dc" element="subject">chromatin</dim:field>
   <dim:field mdschema="dc" element="subject">development</dim:field>
   <dim:field mdschema="dc" element="subject">epigenomics</dim:field>
   <dim:field mdschema="dc" element="subject">genomics</dim:field>
   <dim:field mdschema="dc" element="subject">Molecular biology</dim:field>
   <dim:field mdschema="dc" element="subject">Cellular biology</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="other">Genetics</dim:field>
   <dim:field mdschema="dc" element="title">Brahma Associated Factor Complex in development and disease</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="terms">Restrict to UW for 1 year -- then make Open Access</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="lift">2027-02-05T19:36:18Z</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>